IP Verse

Schering competitive analysis

Latest publications and patents of Schering New

Explore the latest publications and patents granted to Schering, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Schering

EP2399588
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral PolymeraseRevoked
EP1747001
Oct 10, 2018Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive RegimensRevoked
EP2475388
Nov 8, 2017Use Of Il-33 Antagonists To Treat Fibrotic DiseaseOpposition Rejected
EP5252729
Oct 12, 1993Extraction Of Compounds From Plant Materials Using Supercritical Fluids -

Latest patents of Schering opposed by its competitors

Explore Schering's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2399588
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase1
EP1747001
Oct 10, 2018Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive Regimens2
EP2475388
Nov 8, 2017Use Of Il-33 Antagonists To Treat Fibrotic Disease1

Latest PTAB cases involving Schering

Discover the latest PTAB cases involving Schering, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Schering with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SCHERING - 4 - - Non-Active
ELI LILLY4251715Balanced
GILEAD SCIENCES52386Balanced